Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -8.17 | -7.47 | -7.78 | -6.28 | -9.34 | -16.31 | -12.62 | -9.37 | -7.73 | -13.26 | 0.21 | -21.09 | -6.93 | -6.35 | -3.85 | -4.55 | -4.13 |
PEG Ratio | 0.63 | -0.39 | 0.33 | -0.15 | -0.23 | n/a | 0.32 | 0.47 | -0.12 | 0.13 | -0.00 | 0.31 | 0.30 | 0.76 | 0.10 | 0.13 | -0.12 |
PS Ratio | 28.85 | 24.74 | 23.43 | 29.13 | 30.06 | 31.62 | 28.79 | 42.67 | 65.55 | 51.62 | 61.50 | 62.53 | 54.51 | 54.43 | 41.26 | 73.84 | 92.33 |
PB Ratio | 2.67 | 2.64 | 2.13 | 2.14 | 2.13 | 2.61 | 1.84 | 2.09 | 1.84 | 1.71 | 1.59 | -1.98 | -2.05 | -2.4 | -1.68 | -3.17 | -3.53 |
P/FCF Ratio | 10.31 | -424.88 | -75.85 | -93.31 | -391.73 | -362.79 | -180.25 | -44.15 | -56.16 | -6.08 | -34.68 | -46.55 | -27.33 | -18.97 | -11.71 | -18.97 | -18.38 |
P/OCF Ratio | 10.31 | -514.38 | -76.07 | -94.07 | -426.61 | -650.38 | -181.77 | -47.17 | -60.85 | -6.1 | -34.59 | -46.91 | -27.59 | -19.17 | -11.98 | -19.03 | -18.84 |
OCF/S Ratio | 2.80 | -0.05 | -0.31 | -0.31 | -0.07 | -0.05 | -0.16 | -0.9 | -1.08 | -8.47 | -1.78 | -1.33 | -1.98 | -2.84 | -3.44 | -3.88 | -4.9 |
Debt / Equity Ratio | 0.29 | 0.28 | 0.24 | 0.24 | 0.23 | 0.23 | 0.21 | 0.18 | 0.12 | 0.17 | 0.11 | -1.93 | -1.91 | -1.93 | -2.03 | -2.2 | -1.77 |
Quick Ratio | 4.77 | 5.02 | 4.97 | 5.20 | 5.74 | 5.39 | 6.31 | 7.78 | 9.92 | 12.26 | 4.08 | 4.74 | 4.63 | 4.09 | 4.30 | 4.73 | 3.17 |
Current Ratio | 4.77 | 5.02 | 4.97 | 5.20 | 5.74 | 5.39 | 6.37 | 7.82 | 9.98 | 12.31 | 3.60 | 4.74 | 4.63 | 4.26 | 4.50 | 4.96 | 3.39 |
Asset Turnover | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 |
Interest Coverage | -22.45 | -14.31 | -17.2 | -24.39 | -17.82 | -10.02 | -14.38 | -28.39 | -45.29 | -31.64 | -9.19 | 3.21 | -3.2 | -4.82 | -4.5 | -5.52 | -6.93 |
Return on Equity | -0.08 | -0.09 | -0.07 | -0.09 | -0.06 | -0.04 | -0.04 | -0.06 | -0.06 | -0.03 | 1.91 | 0.02 | 0.07 | 0.09 | 0.11 | 0.17 | 0.21 |
Return on Assets | -0.04 | -0.04 | -0.04 | -0.05 | -0.03 | -0.02 | -0.02 | -0.04 | -0.04 | -0.02 | 1.20 | -0.02 | -0.07 | -0.09 | -0.09 | -0.12 | -0.21 |
Return on Invested Capital | -0.04 | -0.05 | -0.04 | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 | -0.05 | -0.03 | -0.02 | 0.02 | -0.12 | -0.17 | -0.15 | -0.17 | -0.28 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.75 | 0.91 | 0.90 | 0.84 | 0.91 | 0.87 | 0.80 | 0.89 | -1.09 | -2.32 | -2.96 | -3.74 |
Net Profit Margin | -0.88 | -0.83 | -0.75 | -1.16 | -0.8 | -0.48 | -0.57 | -1.14 | -2.12 | -0.97 | 73.62 | -0.74 | -1.97 | -2.14 | -2.68 | -4.06 | -5.59 |
Pretax Profit Margin | -0.92 | -0.48 | -0.6 | -1.07 | -0.72 | -0.29 | -0.48 | -1.03 | -2.16 | -0.97 | -1.29 | -0.74 | -1.93 | -2.15 | -2.68 | -4.08 | -5.57 |
Operating Profit Margin | -0.94 | -0.49 | -0.64 | -1.1 | -0.77 | -0.36 | -0.56 | -1.17 | -2.39 | -1.19 | -1.14 | 0.62 | -2.92 | -3.76 | -4.06 | -4.96 | -5.88 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.81 | -0.41 | -0.51 | -0.95 | -0.59 | -0.15 | -0.36 | -0.89 | -1.95 | -0.85 | -1.03 | -1.73 | -2.92 | -1.3 | -4.06 | -2.99 | -4.58 |